171 filings
Page 3 of 9
6-K
3ucp9f azux1jon5
18 Apr 23
GENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-F
4:10pm
F-3
sq4bhtu
18 Apr 23
Shelf registration (foreign)
2:33pm
S-8
jdoick5ccy1cl7ov
18 Apr 23
Registration of securities for employees
2:13pm
6-K
xesk03my6ri6kqvqkz
14 Apr 23
GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update
7:00am
6-K
cuu4ztqp
28 Feb 23
Current report (foreign)
4:10pm
6-K
dwc5vdqxnjzhbv
30 Jan 23
Current report (foreign)
4:10pm
6-K
yt8ye75pi8j
24 Jan 23
GENFIT Announces 2023 Financial Calendar
4:10pm
6-K
ua9a2m ln5
5 Jan 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm
6-K
nzkxx 2mom
17 Nov 22
GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases
4:10pm
6-K
lqla7n55nmgo
10 Nov 22
GENFIT Reports Third Quarter 2022 Financial Information
4:10pm
6-K
61xy3412
25 Oct 22
Current report (foreign)
4:10pm
6-K
2tzy67th
29 Sep 22
GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis
4:10pm
6-K
5ds4qn 1hl8fli1
28 Sep 22
GENFITÂ Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
iij07iutp nndam
19 Sep 22
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases
6:10am
6-K
scvgwp9zra33t 7p
13 Sep 22
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
4:15pm
6-K
jlfg3dl8 xir
8 Jul 22
Current report (foreign)
4:15pm
6-K
dnk7clwh4rv7o9pdss5
25 May 22
Current report (foreign)
4:10pm
6-K
g3v07ls
11 May 22
GENFIT Reports First Quarter 2022 Financial Information
4:10pm
6-K
ep01nho
29 Apr 22
GENFIT Announces Publication of the 2021 Universal
4:10pm